Philips makes another digital buy, as Thermo adds COVID-19 test makerBetween them, Royal Philips and Thermo Fisher have been driving a mini M&A spree in the medical technology Share XPhilips makes another digital buy, as Thermo adds COVID-19 test makerhttps://pharmaphorum.com/news/philips-makes-another-digital-buy-as-thermo-adds-covid-19-test-device/
Biden appoints veteran Woodcock as interim FDA commissionerAgency veteran Dr Janet Woodcock is the new interim FDA commissioner appointed by president Joe Biden to replace Share XBiden appoints veteran Woodcock as interim FDA commissionerhttps://pharmaphorum.com/news/biden-appoints-veteran-woodcock-as-interim-fda-commissioner/
GSK/Merck & Co’s hopeful bintrafusp alfa fails in key lung cancer trialGlaxoSmithKline’s big gamble on a cancer drug developed by Germany’s Merck KGaA looks unlikely to pay out, after Share XGSK/Merck & Co’s hopeful bintrafusp alfa fails in key lung cancer trialhttps://pharmaphorum.com/news/gsk-merck-cos-hopeful-bintrafusp-alfa-fails-in-key-lung-cancer-trial/
Pfizer/BioNTech say COVID-19 vaccine works against UK variantLaboratory studies have confirmed that antibodies stimulated by Pfizer and BioNTech’s COVID-19 vaccine can neutralise the new, more Share XPfizer/BioNTech say COVID-19 vaccine works against UK varianthttps://pharmaphorum.com/news/pfizer-biontech-say-covid-19-vaccine-works-against-uk-variant/
ARK promotes King to client services director, hires Rodriguez as art directorLondon-based comms agency ARK has promoted Nicky King to client services director, with Martina Germinario Rodriguez joining as Share XARK promotes King to client services director, hires Rodriguez as art directorhttps://pharmaphorum.com/news/ark-promotes-king-to-client-services-director-hires-rodriguez-as-art-director/
Lilly bolts on cancer bispecifics with $1.6bn Merus allianceAlways a big player in oncology, Eli Lilly has fallen behind some of its rivals when it comes Share XLilly bolts on cancer bispecifics with $1.6bn Merus alliancehttps://pharmaphorum.com/news/lilly-bolts-on-cancer-bispecifics-with-1-6bn-merus-alliance/
Sobi gets EU nod for Doptelet in rare blood disorder ITPSweden’s Sobi has secured EU approval for Doptelet in primary chronic immune thrombocytopenia (ITP), an indication that the Share XSobi gets EU nod for Doptelet in rare blood disorder ITPhttps://pharmaphorum.com/news/sobi-gets-eu-nod-for-doptelet-in-rare-blood-disorder-itp/
ConserV Bioscience works on mutation-proof coronavirus shots with US labUK biotech ConserV Bioscience has joined with California’s Lawrence Livermore National Laboratory to develop broad-spectrum coronavirus vaccines as Share XConserV Bioscience works on mutation-proof coronavirus shots with US labhttps://pharmaphorum.com/news/conserv-bioscience-working-on-mutation-proof-coronavirus-shot-with-us-lab/
One in 11 over-65s unwilling to take COVID-19 shotOne in 11 adults aged over 65 have reported a lack of willingness to receive a COVID-19 vaccine, Share XOne in 11 over-65s unwilling to take COVID-19 shothttps://pharmaphorum.com/news/one-in-11-older-patients-unwilling-to-take-covid-19-shot/
